Crossmark

The efficacy and safety of ketamine for depression in patients with cancer: A systematic review

Crossref DOI link: https://doi.org/10.1016/j.ijchp.2023.100428

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Azari, Leila

Hemati, Homa

Tavasolian, Ronia

Shahdab, Sareh

Tomlinson, Stephanie M.

Bobonis Babilonia, Margarita

Huang, Jeffrey

Tometich, Danielle B.

Turner, Kea

Jim, Heather S.L.

Tabriz, Amir Alishahi http://orcid.org/0000-0002-6273-9105
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2023-12-06
More Information

This article is maintained by: Elsevier

Article Title: The efficacy and safety of ketamine for depression in patients with cancer: A systematic review

Journal Title: International Journal of Clinical and Health Psychology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ijchp.2023.100428

Content Type: article

Copyright: © 2023 The Author(s). Published by Elsevier B.V.